17.BETA.-PYRAZOL-3-YL-ANDROST-5-EN-3.BETA.-OL
UNII Q3CIY2CYJG

Substance Identification & Data

This profile provides standardized clinical and technical data for 17.beta.-pyrazol-3-yl-androst-5-en-3.beta.-ol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q3CIY2CYJG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 10163-91-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q3CIY2CYJG

CAS Registry Number

10163-91-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

17.BETA.-PYRAZOL-3-YL-ANDROST-5-EN-3.BETA.-OL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H32N2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XUSSDKMAUSOQSK-SPHVDITISA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

248592

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@]12([C@]([C@@]3(CC=C4[C@@]([C@]3(CC1)[H])(CC[C@@H](C4)O)C)[H])(CC[C@@H]2c5n[nH]cc5)[H])C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 17.beta.-pyrazol-3-yl-androst-5-en-3.beta.-ol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.